Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00423241 · ClinicalTrials.gov registry record · NA
SEMPERFLO* Pain Management System in Inguinal Hernia Repair
A NA study, sponsored by Ethicon.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00423241: Clinical Trial NA study, sponsored by Ethicon.
NCT00423241 is a NA study that was terminated before completion, run by Ethicon. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00423241, a NA study, was terminated before completion, sponsored by Ethicon.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will compare the clinical performance of the SEMPERFLO\* Pain Management System with another commercial pain relief system using 0.5% bupivacaine following unilateral, open, inguinal hernia repair procedures. \*Trademark
Interventions
- DEVICE SEMPERFLO Pain Management System
- DEVICE ON-Q PainBuster Post-Op Pain Relief System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-01 |
| Phase | NA |
Why NCT00423241 stopped before completion
NCT00423241 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which SEMPERFLO Pain Management System is the first listed.
NCT00423241 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00423241 about?
NCT00423241 is a clinical study titled "SEMPERFLO* Pain Management System in Inguinal Hernia Repair". This study will compare the clinical performance of the SEMPERFLO\* Pain Management System with another commercial pain relief system using 0.5% bupivacaine following unilateral, open, inguinal hernia repair procedures. \*Trademark
What is the current status of trial NCT00423241?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2007-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00423241?
The interventions under investigation include: SEMPERFLO Pain Management System (DEVICE), ON-Q PainBuster Post-Op Pain Relief System (DEVICE).
Who is sponsoring clinical trial NCT00423241?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00423241's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia